Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 10 May 2024.Powered by Capital Market - Live News

Dr Lal Pathlabs has received affirmation in credit ratings from CARE for long term bank facilities of Rs 104.17 crore at CARE AA; Stable. Powered by Capital Market - Live News

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 1 February 2024, inter alia, have recommended the second interim dividend of Rs 12 per equity Share (i.e. 120%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Dr Lal Pathlabs rose 53.98% to Rs 81.30 crore in the quarter ended December 2023 as against Rs 52.80 crore during the previous quarter ended December 2022. Sales rose 10.11% to Rs 538.90 crore in the quarter ended December 2023 as against Rs 489.40 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales538.90489.40 10 OPM %26.0923.09 - PBDT151.90114.40 33 PBT115.9076.50 52 NP81.3052.80 54 Powered by Capital Market - Live News

Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 1 February 2024.Powered by Capital Market - Live News